Phase I study of intraperitoneal docetaxel and irinotecan for advanced gastric cancer with peritoneal metastasis
Phase 1
- Conditions
- gastric cancer with peritoneal metastasis
- Registration Number
- JPRN-UMIN000017084
- Lead Sponsor
- The University of Tokyo
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 12
Inclusion Criteria
Not provided
Exclusion Criteria
Other active concomitant malignancies, massive ascites or other severe medical conditions.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method